BOSTON –– When Cam Neely arrived in Boston in 1986, he got to know the city for more than its hockey. Instead of catching a movie in his free time, the now Bruins president found himself in the crowd ...

New York Giants rookie running back Cam Skattebo suffered a gruesome, season-ending ankle injury in a Week 8 loss to the Philadelphia Eagles, ending what was an electrifying debut campaign for the ...

New York Giants running back Cam Skattebo (44) on the field before the game against the Green Bay Packers at MetLife Stadium. Mandatory Credit: Vincent Carchietta-Imagn Images Cam Skattebo spent the ...

Watch highlights of New Orleans Saints defensive end Cam Jordan with the relentless pass rush and strip sack on Kirk Cousins and the Atlanta Falcons in Week 12 of the 2025 NFL season. Watch highlights ...

BOISE, Idaho, Nov. 17, 2025 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that its unaudited condensed ...

Follow tonight's NBA action with the latest highlights and happenings around the league. NBA.com Staff MILWAUKEE, WI – NOVEMBER 20: Tyrese Maxey #0 of the Philadelphia 76ers drives to the basket ...

Over 100 patients treated with AlloNK across autoimmune and oncology indications Refractory rheumatoid arthritis (RA) prioritized as lead indication following FDA Fast Track Designation for AlloNK®, ...

KSHB 41 reporter Grant Stephens covers stories of consumer interest. Share your story idea with Grant. When SNAP benefits were temporarily halted earlier this month, it hit foster families especially ...

Rookie quarterback Cam Ward has shown late-game promise for the Tennessee Titans despite the team's 1-9 record. Ward's former college coach, Eric Morris, believes he thrives in a system that shows his ...

- Closed registered direct offering for aggregate gross proceeds of US$175 million (the “Registered Direct Offering”) led by a syndicate of prominent biopharmaceutical institutional investors - - On ...

CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $524 million EC and U.S. FDA label updates for CARVYKTI ® to include overall survival benefit versus standard of care ...

Recent data presented at EASD and IPSAD provide further validation for SAB-142 as a novel, potentially best-in-class, disease-modifying, immunotherapeutic approach to redefine treatment of Stage 3 T1D ...